Fwd: Map reveals 23 states in revolt

---------- Forwarded message ----------
From: Outsider Club <ww-eletter@angelnexus.com>
Date: Thu, Jan 29, 2015 at 3:05 PM
Subject: Map reveals 23 states in revolt
To: pascal.alter@gmail.com

Forward to a Friend Having trouble viewing this issue? Click here. Dear Reader, 23 states have just made an unbelievable move... They've said NO to Obama. They've said NO to his cronies in the FDA. And they've said NO to Big Pharma. Take a look at the shocking map that reveals this explosive rebellion: What are these states doing? They're bringing to market a new drug called "Delta-9" — a natural painkiller. One that could unleash a $120 billion flood of money on the markets, reports CNBC. And according to a recent Forbes article, "[This move] will make investors extremely wealthy." But not all will win out... You see, "Delta-9" can end pain effectively, safely, and naturally. That's why it's a HUGE threat to the drug industry's $635 billion pain market. It's also a huge threat to the FDA and EVEN the Obama administration — which relies on lobbying dollars from Big Pharma. That's why Obama is doing everything in his power to suppress this story. And that's why the drug companies are unleashing $27 billion to shut the media up. But the floodgates are open... The states are taking action... And there's no stopping it now. Click here to see this incredible story. Godspeed, Jimmy Mengel Investment Director, The Crow's Nest This email was sent to pascal.alter@gmail.com . You can manage your subscription and get our privacy policy here. Outsider Club, Copyright © 2015, Angel Publishing LLC, 111 Market Place #720, Baltimore, MD 21202. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law. Please note: It is not our intention to send email to anyone who doesn't want  (....)